| Product Code: ETC8272395 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Arthritis Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Arthritis Market - Industry Life Cycle |
3.4 Mexico Arthritis Market - Porter's Five Forces |
3.5 Mexico Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.6 Mexico Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.7 Mexico Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.8 Mexico Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.9 Mexico Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.10 Mexico Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.11 Mexico Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Mexico Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of arthritis in Mexico |
4.2.2 Growing geriatric population in Mexico |
4.2.3 Rising awareness about arthritis and its management in the country |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in certain regions of Mexico |
4.3.2 High cost of arthritis treatments and medications |
4.3.3 Lack of reimbursement policies for arthritis treatments in Mexico |
5 Mexico Arthritis Market Trends |
6 Mexico Arthritis Market, By Types |
6.1 Mexico Arthritis Market, By Rheumatoid Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Arthritis Market Revenues & Volume, By Rheumatoid Drug Type, 2021- 2031F |
6.1.3 Mexico Arthritis Market Revenues & Volume, By Biologics, 2021- 2031F |
6.1.4 Mexico Arthritis Market Revenues & Volume, By Non-Biologics, 2021- 2031F |
6.1.5 Mexico Arthritis Market Revenues & Volume, By Steroids, 2021- 2031F |
6.1.6 Mexico Arthritis Market Revenues & Volume, By Analgesics, 2021- 2031F |
6.1.7 Mexico Arthritis Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.1.8 Mexico Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Arthritis Market, By Rheumatoid Treatment |
6.2.1 Overview and Analysis |
6.2.2 Mexico Arthritis Market Revenues & Volume, By Synovectomy, 2021- 2031F |
6.2.3 Mexico Arthritis Market Revenues & Volume, By Tendon Repair, 2021- 2031F |
6.2.4 Mexico Arthritis Market Revenues & Volume, By Joint Fusion, 2021- 2031F |
6.2.5 Mexico Arthritis Market Revenues & Volume, By Symptomatic Treatment, 2021- 2031F |
6.2.6 Mexico Arthritis Market Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021- 2031F |
6.2.7 Mexico Arthritis Market Revenues & Volume, By DMARD Therapies, 2021- 2031F |
6.3 Mexico Arthritis Market, By Rheumatoid Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Mexico Arthritis Market Revenues & Volume, By C.R.P. Test, 2021- 2031F |
6.3.3 Mexico Arthritis Market Revenues & Volume, By C.C.P., 2021- 2031F |
6.3.4 Mexico Arthritis Market Revenues & Volume, By E.S.R. Test, 2021- 2031F |
6.4 Mexico Arthritis Market, By Osteoarthritis Type |
6.4.1 Overview and Analysis |
6.4.2 Mexico Arthritis Market Revenues & Volume, By Hip, 2021- 2031F |
6.4.3 Mexico Arthritis Market Revenues & Volume, By Spinal, 2021- 2031F |
6.4.4 Mexico Arthritis Market Revenues & Volume, By Knee, 2021- 2031F |
6.4.5 Mexico Arthritis Market Revenues & Volume, By Foot and Ankle, 2021- 2031F |
6.4.6 Mexico Arthritis Market Revenues & Volume, By Shoulder, 2021- 2031F |
6.4.7 Mexico Arthritis Market Revenues & Volume, By Hand, 2021- 2031F |
6.5 Mexico Arthritis Market, By Osteoarthritis Diagnosis |
6.5.1 Overview and Analysis |
6.5.2 Mexico Arthritis Market Revenues & Volume, By Imaging, 2021- 2031F |
6.5.3 Mexico Arthritis Market Revenues & Volume, By Joint Fluid Analysis, 2021- 2031F |
6.5.4 Mexico Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Arthritis Market, By Osteoarthritis Treatment |
6.6.1 Overview and Analysis |
6.6.2 Mexico Arthritis Market Revenues & Volume, By Medication, 2021- 2031F |
6.6.3 Mexico Arthritis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.6.4 Mexico Arthritis Market Revenues & Volume, By Assistive Devices, 2021- 2031F |
6.6.5 Mexico Arthritis Market Revenues & Volume, By Surgery, 2021- 2031F |
6.6.6 Mexico Arthritis Market Revenues & Volume, By Therapy, 2021- 2031F |
6.7 Mexico Arthritis Market, By Route of Administration |
6.7.1 Overview and Analysis |
6.7.2 Mexico Arthritis Market Revenues & Volume, By Oral, 2021- 2031F |
6.7.3 Mexico Arthritis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.8 Mexico Arthritis Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 Mexico Arthritis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.8.3 Mexico Arthritis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.8.4 Mexico Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.5 Mexico Arthritis Market Revenues & Volume, By Medical Institutes, 2021- 2031F |
6.8.6 Mexico Arthritis Market Revenues & Volume, By Research Organizations, 2021- 2031F |
6.8.7 Mexico Arthritis Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Arthritis Market Import-Export Trade Statistics |
7.1 Mexico Arthritis Market Export to Major Countries |
7.2 Mexico Arthritis Market Imports from Major Countries |
8 Mexico Arthritis Market Key Performance Indicators |
8.1 Average waiting time for arthritis treatment in healthcare facilities |
8.2 Percentage of population receiving regular arthritis screenings |
8.3 Number of arthritis awareness campaigns conducted in Mexico |
8.4 Adoption rate of new arthritis treatments and therapies |
8.5 Patient satisfaction with arthritis management services provided |
9 Mexico Arthritis Market - Opportunity Assessment |
9.1 Mexico Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
9.2 Mexico Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
9.3 Mexico Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
9.4 Mexico Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
9.5 Mexico Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
9.6 Mexico Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
9.7 Mexico Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Mexico Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Mexico Arthritis Market - Competitive Landscape |
10.1 Mexico Arthritis Market Revenue Share, By Companies, 2024 |
10.2 Mexico Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here